72 related articles for article (PubMed ID: 28112372)
1. Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.
Lu Q; Yuan L; Xu H; Huang X; Yang Z; Yi J; Ni B; Chen Y; Deng H
Mol Med Rep; 2017 Mar; 15(3):1426-1430. PubMed ID: 28112372
[TBL] [Abstract][Full Text] [Related]
2. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase (TYR) gene sequencing and literature review reveals recurrent mutations and multiple population founder gene mutations as causative of oculocutaneous albinism (OCA) in Pakistani families.
Shakil M; Harlalka GV; Ali S; Lin S; D'Atri I; Hussain S; Nasir A; Shahzad MA; Ullah MI; Self JE; Baple EL; Crosby AH; Mahmood S
Eye (Lond); 2019 Aug; 33(8):1339-1346. PubMed ID: 30996339
[TBL] [Abstract][Full Text] [Related]
4. Missing Heritability in Albinism: Deep Characterization of a Hungarian Albinism Cohort Raises the Possibility of the Digenic Genetic Background of the Disease.
Nagy N; Pal M; Kun J; Galik B; Urban P; Medvecz M; Fabos B; Neller A; Abdolreza A; Danis J; Szabo V; Yang Z; Fenske S; Biel M; Gyenesei A; Adam E; Szell M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279271
[TBL] [Abstract][Full Text] [Related]
5. Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population.
Shahzad M; Yousaf S; Waryah YM; Gul H; Kausar T; Tariq N; Mahmood U; Ali M; Khan MA; Waryah AM; Shaikh RS; Riazuddin S; Ahmed ZM;
Sci Rep; 2017 Mar; 7():44185. PubMed ID: 28266639
[TBL] [Abstract][Full Text] [Related]
6. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Nykamp K; Anderson M; Powers M; Garcia J; Herrera B; Ho YY; Kobayashi Y; Patil N; Thusberg J; Westbrook M; ; Topper S
Genet Med; 2017 Oct; 19(10):1105-1117. PubMed ID: 28492532
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
[TBL] [Abstract][Full Text] [Related]
8. Statistical features of human exons and their flanking regions.
Zhang MQ
Hum Mol Genet; 1998 May; 7(5):919-32. PubMed ID: 9536098
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism.
Chan HW; Schiff ER; Tailor VK; Malka S; Neveu MM; Theodorou M; Moosajee M
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808351
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a series of 990 index patients with albinism.
Lasseaux E; Plaisant C; Michaud V; Pennamen P; Trimouille A; Gaston L; Monfermé S; Lacombe D; Rooryck C; Morice-Picard F; Arveiler B
Pigment Cell Melanoma Res; 2018 Jul; 31(4):466-474. PubMed ID: 29345414
[TBL] [Abstract][Full Text] [Related]
12. Native American genetic ancestry and pigmentation allele contributions to skin color in a Caribbean population.
Ang KC; Canfield VA; Foster TC; Harbaugh TD; Early KA; Harter RL; Reid KP; Leong SL; Kawasawa Y; Liu D; Hawley JW; Cheng KC
Elife; 2023 Jun; 12():. PubMed ID: 37294081
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel variations of oculocutaneous albinism type 2 with Prader-Willi syndrome/Angelman syndrome in two Chinese families.
Chen X; Fang Z; Pang T; Li D; Lei J; Jiang W; Li H
Front Genet; 2023; 14():1135698. PubMed ID: 36950135
[No Abstract] [Full Text] [Related]
14. Diagnostic Yield of Genetic Testing for Ocular and Oculocutaneous Albinism in a Diverse United States Pediatric Population.
Chan KS; Bohnsack BL; Ing A; Drackley A; Castelluccio V; Zhang KX; Ralay-Ranaivo H; Rossen JL
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672876
[TBL] [Abstract][Full Text] [Related]
15. Assessing Foveal Structure in Individuals with
Ayala GD; Linderman RE; Valenzuela RK; Woertz EN; Brilliant M; Tarima S; Carroll J
Ophthalmol Sci; 2021 Dec; 1(4):100077. PubMed ID: 36246950
[TBL] [Abstract][Full Text] [Related]
16. The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism.
Michaud V; Lasseaux E; Green DJ; Gerrard DT; Plaisant C; ; Fitzgerald T; Birney E; Arveiler B; Black GC; Sergouniotis PI
Nat Commun; 2022 Jul; 13(1):3939. PubMed ID: 35803923
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic variations in ocular features among siblings with oculocutaneous albinism.
Bhate M; Lalwani S; Chakrabarti S
Indian J Ophthalmol; 2022 Jul; 70(7):2511-2515. PubMed ID: 35791147
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmological Manifestations of Oculocutaneous and Ocular Albinism: Current Perspectives.
Neveu MM; Padhy SK; Ramamurthy S; Takkar B; Jalali S; Cp D; Padhi TR; Robson AG
Clin Ophthalmol; 2022; 16():1569-1587. PubMed ID: 35637898
[TBL] [Abstract][Full Text] [Related]
19. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
